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The increasing use of molecular typing is transforming surveillance and the control of diseases in 
people and animals (Kao et al. 2014; Struelens & Brisse 2013). Molecular and genomic data are 
becoming increasingly available and affordable and completely new technologies have emerged 
in recent years, all with their specific advantages and disadvantages (Sabat et al. 2013).  
Furthermore established technologies such as pulsed-field gel electrophoresis (PFGE) and 
multilocus sequence typing (MLST), which itself has only emerged in the last decade, are being 
replaced by whole genome sequencing (WGS). Advances in genetic and genomic 
characterisation create remarkable possibilities for health, in particular where typing data are 
combined with other, epidemiological data such as individual characteristics including 
demographic data, exposures, time, and geographic information (Goering et al. 2013). Overall 
molecular typing complements traditional epidemiological data (EFSA BIOHAZ Panel (EFSA 
Panel on Biological Hazards) 2013) and can support both control- and strategy-focussed 
surveillance, i.e. surveillance aimed at the detection of outbreaks that require a specific response 
or surveillance providing information for preventive public health action (Muellner et al. 2013). 
In outbreak investigation, for instance, the use of molecular markers can substantially improve 
the precision of case definition. This, in return, can reduce misclassification bias and increase the 
likelihood of identifying controllable risk factors, thus improving power of the study (Höfler 
2005). The routine collection of molecular typing data has also been the driver behind recent 
advances in source attribution of food-borne pathogens (Muellner et al. 2013). In particular for 
multi-host pathogens, where the contribution of individual sources of infection can be difficult to 
evaluate, these tools can make an important contribution by enhancing the ability to detect 
shared or separated transmission pathways in different host species (Mather et al. 2013). With 
the growing availability of typing tools, opportunities are plentiful to increase, for example, the 
resolution of surveillance data to advance both control- and strategy-focussed approaches. 
Advances in sampling designs could substantially increase the added value obtained by 
extending surveillance efforts to the molecular level. However to date, few recommendations   
for good practice in the design of studies or continuous, systematic sampling efforts using 
molecular-level pathogen data and feedback mechanisms to inform action (e.g. Döpfer et al. 
2008; Muellner et al. 2013; EFSA 2014).  
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Although molecular typing offers many opportunities and costs (e.g. per per unit of DNA) 
continue to drop, the costs of typing still have to be justified in times of ever-increasing resource 
constraints. The value of the additional information gained by using methods with higher 
specificity has to be weighed against the benefits of utilizing the same resources to gather a 
larger number of samples or for other types of analyses. In particular, if observations become too 
few, the epidemiological analysis of the data generated can become very difficult, affecting for 
example the ability to detect disease trends. Also, the need to purchase laboratory equipment 
must be balanced against the need for acquisition of other assets such as IT infrastructure. 
Further, the use of molecular typing is no substitute for sound surveillance design. As for any 
surveillance approach, information value is highly dependent on system attributes such as data 
quality and representativeness (Drewe et al. 2012). The value of specific molecular surveillance 
activities yet needs to be fully and formally evaluated, including an assessment of attributes such 
as usefulness, simplicity, data quality, flexibility, acceptability, representativeness, timeliness 
and value for money (e.g. Drewe et al. 2012). Examples of such evaluation of ongoing molecular 
surveillance programmes would be highly desirable.  
 
We believe that an accurate and agreed terminology is an important first step towards better 
integration of molecular surveillance into existing surveillance standards, protocols and working 
principles.  This article therefore aims to propose a formal definition of molecular surveillance. 
Furthermore we provide an epidemiologists’ perspective on the use of molecular tools in disease 
and hazard surveillance to complement previous work that focuses on technical, pathogen or 
disease specific aspects of surveillance (European Centre for Disease Prevention and Control 
(ECDC) - Health Comunication Unit - Eurosurveillance Editorial Team 2013; Nadon et al. 
2013). 
 
In accordance with the most up-to-date definition of surveillance provided by the RISKSUR 
Consortium (The RISKSUR Project 2014) we propose that molecular surveillance is defined as 
”the systematic, continuous or repeated, measurement, collection, collation, analysis, 
interpretation and timely dissemination of molecular-level information about micro-organisms. 
These data are then used to describe health hazard occurrence and to contribute to the planning, 
implementation, and evaluation of risk mitigation actions’. For completeness this definition 
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could also be extended to monitoring and the term molecular monitoring used, where molecular-
level information is generated by monitoring activities. 
 
In molecular surveillance, conventional surveillance approaches are utilised, with molecular 
typing added where considered necessary to improve the resolution of the data (Denisuik et al. 
2013). Such surveillance often involves molecular typing of selected isolates only. This is 
currently the most common form. In human clinical microbiology, which encompasses both 
patient diagnostics and public health microbiology, efforts are underway to implement next 
generation sequencing (NGS) as part of routine diagnostics and surveillance. Use of NGS is 
envisaged for all clinical isolates, rather than a subset of isolates, but the availability of isolates 
would be driven by presentation of clinical cases and not by pre-determined study designs 
(Didelot et al. 2012). Where possible molecular information should form an integral part of the 
surveillance design, rather than an added component. In such an approach, sample collection is 
informed by aspects of both host and pathogen populations or sources under investigation. 
Molecular information is also explicitly relevant for the surveillance objective. For example, the 
heterogeneity of the pathogen population, the molecular clock speed of various markers (i.e. their 
pace of evolution) relative to the spatio-temporal scale of the investigation, and the aim of the 
investigation would inform the study design, including sample collection strategy, choice of 
isolates to characterize within a sample, and molecular marker selection. Such surveillance 
would be based on both macro- and molecular-level characteristics and would make full use of 
molecular information.  
 
In molecular surveillance, just like in any epidemiological and evolutionary analyses, the 
molecular tools deployed need to be fit-for-purpose and ideally are optimised during their 
development for the outcome in mind (Muellner et al. 2013). Of particular importance in the 
context of molecular surveillance is the link between sensitivity and specificity of the 
surveillance system as a whole and the sensitivity and specifity of the molecular method utilised. 
Formal evaluation of not only the analytical, but alo the diagnostic sensitivity and specificity of 
the molecular methods and detection protocol used in the context of surveillance is therefore 
highly recommened to meet the minimum standard of performance required. For example a 
molecular test might lack the level of sensitivity or specificity provided by a non-molecular test, 
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such as a serological essay. If not accounted for in the design, this might negatively affect the 
ability of the surveillance system to meet its objective, albeit a high level of resolution is 
achieved at the micro-organism level. 
  
Just like any other population-focused approach, molecular surveillance needs to be supported by 
sound epidemiological concepts and designs, as bias affects molecular studies as well as studies 
that do not include molecular data. One important advantage of molecular surveillance is the 
ability to reduce of misclassification bias resulting from improved, more precise, case 
definitions. A simple example of this in anoutbreak setting has been described by Muellner et al. 
(2011). However this is not always the case and will be highly dependent on the level of 
discrimination of the typing methods and how it matches the speed of evolution of the pathogen. 
Where the method applied is too discriminatory, another type of missclassification can be 
introduced and in consequence  related cases may not be not recognised as such  (Petersen et al. 
2011).  
 
It is worth noting that all bias commonly reported in epidemiological research (i.e. confounding, 
misclassification of exposures, and selection and collider-stratification biases) can still affect 
molecular surveillance activities. In some instances, bias can even be created or increased by the 
integration of molecular methods. This would be the case, for example, when only a subset of the 
isolates collected is submitted for further characterization. In such case, a planned selection of 
the isolates using randomized and, if relevant, stratified sampling procedures is essential to 
maintain the original sampling fractions and avoid introducing selection bias. Molecular typing 
is no substitute for sound surveillance design, and sample size, unit of analysis and sources of 
bias have to be carefully considered.  
 
We need to be aware of the fact that currently molecular strain typing, regardless of the degree of 
sophistication of the technology, is commonly applied to an incomplete data set since not all 
relevant clinical or non-clinical isolates may be available and, even when next generation 
sequencing (NGS) is used, all isolate characteristics, e.g. repeat regions that occur in multiple 
copies throughout the genome, may not have been analysed (Goering et al. 2013). In the absence 
of epidemiological metadata, typing is at risk of being no more than an inefficient use of 
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laboratory and bioinformatics resources producing data of mediocre quality and potentially 
leading to inappropriate disease control decisions.  Although the amount of molecular data is 
expected to increase, e.g. as traditional multi-locus-sequence-typing (MLST) is replaced by 
whole genome sequencing (WGS) for bacterial pathogens (Spratt 2012) and in-silcio typing, 
where molecular typing results are computed from WGS data (Carrillo et al. 2012), the 
information utility will continue to be highly dependent on the epidemiological metadata. This 
has recently been illustrated using sequence information of influenza strains (VonDobschuetz et 
al. 2015). In this example, the lack of metadata severely limited the utility of sequencing to 
provide information for early warning of zoonotic influenza strain emergence. 
 
The objectives of molecular surveillance can be diverse and include the detection of a specific 
pathogenic strain or virulence trait, such as toxin production or antimicrobial resistance, the 
assessment of species or strain abundance or richness, or the investigation of transmission 
chains. As in traditional surveillance, the surveillance objective  should drive the study design to 
assure the generation of relevant molecular data. Sampling in the context of molecular 
surveillance can be particularly problematic. When using molecular methods, it is possible to 
create a substantial number of observations based on a single sample. For example, a faecal 
sample may contain many bacterial species as well as multiple strains within these species, and 
in addition to this the observed species and strain composition will vary over time. Potential 
sources of strains of interest may be missed if a limited number of isolates per sample is 
characterized (Döpfer et al. 2008). Furthermore, an understanding of the within-host or within-
sample heterogeneity is needed because incomplete sampling of this heterogeneity may result in 
erroneous interpretations regarding epidemiological relatedness. For example, quasispecies 
clouds of viruses infecting epidemiologically independent individuals may show some overlap 
due to within-host heterogeneity, making it difficult to rule out epidemiological links based on 
molecular data alone (Smith & Waterman 1992). Similarly, within-host hetereogeneity of 
genome sequences for bacterial species affects our ability to infer directionality in transmission 
chains between individuals, including people and animals (Harris et al. 2013; Harrison et al. 
2013). 
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Despite the sophistication and information density offered by genomic or metagenomic analysis 
and recent advances in computational biology (Pybus et al. 2013), selection of biological 
samples will continue to affect the outcome of molecular analyses. Current sequence collections 
are likely to be heavily biased, e.g. by host species or geographic origin, and provide a very 
limited basis to inform decision making when epidemiological principles used to inform the 
collection of different isolates are not reported. This is of particular importance where typing 
results are included in openly accessible databases. In this later case, epidemiological data are 
often very scarce and sampling strategies used are not reported and also can be heterogeneous 
within a given database (van den Borne et al. 2010). Due to its shortcoming the data is generally 
of limited use to risk assessment, trend analysis or source attribution or other population-based 
approaches. Furthermore the content of openly accessible databases, while certainly of value, is 
often wrongly referred to as ‘surveillance data’. In an attempt to strengthen the reporting of 
results of molecular epidemiological studies an extension of the STROBE statement has recently 
been published (Field et al. 2014). 
 
Care should also be taken when interpreting molecular data in the context of surveillance as the 
evolutionary mechanisms that underlie genetic polymorphism may not necessarily relate to 
epidemiological processes. Epidemiological concordance should be of primary concern when 
developing molecular surveillance activities, and typing concordance should be seen as very 
valuable, but adjunct information, rather than the other way around.  Different markers within a 
species may evolve by different biological mechanisms, which may result in the almost 
independent evolution of the core genome of a pathogen and clinically relevant characteristics 
such as antimicrobial resistance, as recently shown for Salmonella DT104 (Mather et al. 2013). 
The choice of markers (molecular or genomic) used in surveillance is crucial and attention 
should be given to the ’clock-speed’ i.e. does the marker selected evolve at the appropriate pace 
to provide tracking over the spatiotemporal scale of interest (Struelens et al. 1998). With the 
increasing availability of Next Generation Sequencing (NGS), understanding of the association 
between markers and epidemiological processes will continue to be critical in molecular 
surveillance. For example, in the analysis of the molecular epidemiology of methicillin resistant 
Staph. aureus (MRSA) in humans and animals, separate analyses were conducted for the core 
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and accessory genome of the pathogen because they evolve in different ways, and consequently 
correlate with epidemiological processes in different ways  (Price et al. 2012).  
 
A key need of the discipline is also the development of combined molecular and epidemiological 
criteria that define the “sameness” of isolates for example in the context of outbreak 
investigation, such as the Tenover criteria for Pulsed-Field Electrophoresis Profiles (PFGE) used 
for the investigation of outbreaks in hopsital settings. While concepts like similarity of strains, 
host-association and relatedness of strains provide a first decision-basis for molecular 
epidemiology (Muellner et al. 2013), more standardised criteria are much needed in particular for 
WGS data.   
 
Molecular epidemiology should be integrated into routine surveillance activities rather than 
conducted ad hoc. This was also one of the main conclusions following a major outbreak of 
foodborne disease caused by E. coli 0104:H4 in Germany (STEC Workshop Reporting Group 
2011). Ideally, performance and utility of molecular tools should be considered for surveillance 
already during their development (Muellner et al. 2013). The addition of WGS data from high 
through-put sequencing platforms could potentially improve currently available typing tools for 
source attribution (Anonymous 2014), and this could also be of value for molecular surveillance. 
The work on influenza virus is currently among the most advanced in this area including  the 
EMPRES-i genetic surveillance module, which links epidemiological and genetic information 
and thus supports risk assessments of human-animal influenza threats (Claes et al. 2014). Bias 
can easily be introduced by population characteristics and the spatial and temporal characteristics 
of the samples. This is of particular importance when isolates are compared across large spatial 
or temporal scales. Spatial and temporal scales are often interpreted as proxies for the number of 
pathogen replication cycles and hence the likelihood of accumulation of mutations. However our 
understanding of this important relationship still suffers from serious shortcomings e.g. little is 
known about the impact of latent versus active infection on mutation and fixation rates, about the 
impact of transfer to a new host species, or about the difference between short- and long-term 
evolution (Muellner et al. 2011). A recent Scientific Opinion published by the European Food 
Safety Authority ((EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards) 2013)) provides 
an in-depth evaluation of molecular typing methods for major food-borne microbiological 
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hazards and their use for attribution modelling, outbreak investigation and scanning surveillance 
and further discusses some of the points introduced in this manuscript. 
 
Risk-based surveillance serves as a good example as to how surveillance and other 
epidemiological approaches can be integrated. Following their successful application, including 
their use during the bovine spongiform encephalopathy (BSE) epidemic, risk-based approaches 
are increasingly seen as an efficient design to conduct disease surveillance (The RISKSUR 
Project 2014). The basis of this approach is the combined application of risk assessment methods 
with traditional design approaches to ensure appropriate and cost-effective data collection (Stärk 
et al. 2006). Similarly, molecular epidemiology tools could be integrated in risk-based 
surveillance to create a new generation of designs combining the benefits of both approaches. 
This would be of particular value where a link could be made between disease risk and, for 
example, changes in virulence markers or pathogen evolution (Delannoy et al. 2014).  
 
In conclusion, molecular and genomic typing technologies can add value to infectious disease 
surveillance and will be key to timely tracing of future disease outbreaks and for progress on 
important public health issues. However, typing is not a substitute for sound surveillance design. 
Further, it should not be seen as a parallel form of surveillance but as an integral part of the 
combined analysis. There is a need to further investigate the interface between molecular 
surveillance and more established epidemiological approaches. More work is necessary to 
develop good practice principles for molecular surveillance. Since the nineties, microbiology has 
been completely transformed by the development of molecular diagnostic methods. Likewise, 
greater availability of these molecular methods has massively changed epidemiological research, 
more particularly research in food safety and animal health surveillance. We now also need 
concepts and methods for “next generation surveillance”. This will require a deeper 
understanding of both the potential and limitations of molecular techniques among 
epidemiologists and the development of accepted standards. This could be achieved by specific 
training and by increased interaction and deep collaboration for example between 
epidemiologists and diagnosticians or bioinformaticians.  
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